Implementation in Ohio’s Regional Psychiatric Hospitals.

Slides:



Advertisements
Similar presentations
Sharon Stancliff, MD Caroline Rath, PA-C Harm Reduction Coalition New York, NY USA.
Advertisements

Peer naloxone – present or future? Issues for service delivery Nigel Modern.
The Washington State Pharmacist Perspective
John R. Kasich, Governor Orman Hall, Director 1. John R. Kasich, Governor Orman Hall, Director 2  Tolerance  Euphoria  Withdrawal.
Deaths Avoided With Naloxone What is Naloxone? Naloxone commonly known as Narcan is a medication that can reverse and overdose caused by an opioid drug.
DBHDS Vision: A life of possibilities for all Virginians Treatment for Opioid Addiction Public Community Treatment in Virginia Virginia Heroin and Prescription.
PERMEATING BORDERS OVERDOSE PREVENTION Summer Conference 2014 July 24, 2014 ACOPC Allegheny County Overdose Prevention Coalition Presents.
Opioid Overdose Prevention for Law Enforcement and First Responders Sponsored by the NC Office of EMS.
San Francisco Bay Area Drug Trends and Effective Intervention Strategies Alice Gleghorn, Ph.D County Alcohol and Drug Program Administrator San Francisco.
Project Coordinator Overdose Prevention Project, Prevention Point Pittsburgh Alice Bell, LCSW.
Opioid Safety Phillip Coffin, MD, MIA Director of Substance Use Research San Francisco Dept. of Public Health Assistant Clinical Professor University of.
Addiction Medicine Education, Patient Care and Research Update Alex Walley, MD, MSc Clinical Addiction Research and Education (CARE)
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, Deputy Director Andrea Boxill, Deputy Director Governor’s Cabinet Opiate Action Team.
Serving our community by improving health The Addiction Crisis November 2014.
LEGAL AND ILLEGAL SUBSTANCES. LEGAL DRUGS Legal drugs are considered permissible for use, and are either prescribed by a physician (prescription medications)
Strategies for Incorporating OD Prevention Into Your Work Eliza Wheeler Drug Overdose Prevention & Education (DOPE) Project Harm Reduction Coalition
1 Mental Health and Substance Abuse Services Division Association of Substance Abuse Providers Mike Maples October 5, 2011.
Naloxone (Narcan) A true opioid overdose antidote.
Recommendations on the Management of Opioid Overdose Ruth Birgin.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, MA Deputy Director 1.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, MA Deputy Director 2/23/20151.
OVERDOSE SOLUTIONS 2013 PROJECT LIFE LINE AN ACOPC INITIATIVE Sherry Rickard-Aasen.
Rx for Success Next Steps to Prevent Prescription Drug Abuse Rebecca Hebner, MPH Substance Abuse Prevention Systems Coordinator.
What are we doing in Southern Oregon? Concerns about opioid prescribing practices.
1 Alcohol and Substance Abuse Council of Jefferson County, Inc. 167 Polk Street, Suite 320 Watertown, New York Voice: ; Fax: ;
Quaboag Hills Community Coalition Substance Use Task Force October 20, 2014 Overview of the Strategic Prevention Framework (SPF) “Road Map” What are Evidence-Based.
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.
MBEMSC /PIER Committee
Expanding Authority for MAT, New Initiatives and Next Steps Brad DeCamp SOTA Ohio Mental Health & Addiction Services.
KNOW THE FACTS: SERIES II Trends and Facts on Prescription Drug Abuse This document is confidential and is intended solely for the use and information.
Trends in Opioid Use and Overdose in BC: Making the case for greater availability of Take Home Naloxone programs Ashraf Amlani Harm Reduction Epidemiologist.
Heroin Associated Deaths in Greene County, Ohio Jane McClelland, BSN, RN, Public Health Nurse Melissa Howell, Health Commissioner Don Brannen, PhD, MHSA,
Opiate Management Douglas Keehn DO Adjunct Assistant Clinical Professor University Wisconsin Board Certified Anesthesia & Pain Management.
1 December 8, 2015 Crista M. Taylor, LCSW-C Director, Information, Planning and Development Adrienne Breidenstine, MSW Director of Opioid Overdose Prevention.
The Heroin Epidemic in rural Maryland Rural Health Learning Collaboration Sept. 28, 2015 James A. Cockey, MD, FACP Deputy Health Officer.
Naloxone nasal spray in Norway Thomas Clausen Professor (Dr. med) 5. November 2015.
NALOXONE Presented by The RASE Project. Scope Of The Problem Opiate overdose is a major public health problem in the United States. Overdoses have increased.
Saving Lives- A Case for Stocking Narcan in our School Health Offices
The Impact on Caregivers of Young Adult Opioid Use Sarah Bagley MD Addiction Medicine Fellow Clinical Addiction Research and Education Unit Boston University.
Naloxone: Prescribing and Dispensing
Naloxone for Entities & Laysavers Aaron Kochar, J.D.
Rural Hospital Taking Lead in CSR Abuse Educational Efforts & Outcomes Ann Vermilion, MBA, FACHE Admin. Director Medical Staff Services & Community Outreach.
Bystander Naloxone Training Saves Lives. Death rates are spiraling out of control--for both prescription opioids and heroin! Graphic: Nytimes.com.
Overdose Prevention Pilot Project Cross Systems Collaboration. Naloxone Distribution In cooperation with LA Community Health Project June 4, 2014, VCBH,
Substance Use Disorders and Overdose: The Basics Public Curricula – Essential Knowledge for Families and Communities Core Component.
Denis G. Patterson, DO ECHO Project April 20, 2016 CDC Guidelines for Prescribing Opioids for Chronic Pain.
The AMA: Reducing Opioid Abuse in America Patrice A. Harris, MD, MA Board Chair American Medical Association September 2016.
Pharmacist Role in Naloxone Prescribing
OPIOID EPIDEMIC.
How big is the problem? The Centers for Disease Control and Prevention (CDC) classifies prescription drug abuse as the fastest growing drug issue and epidemic.
Nebraska Prescription Drug Overdose Prevention Program Efforts
Caldwell County Narcotic Initiative
Neonatal Abstinence Syndrome (NAS) Program Overview
An overdose Reduction PlaN
McLean Hospital Division of Alcohol and Drug Abuse
Opioid Crisis A Call to ACTION
Experiences from a national overdose prevention strategy: Nasal naloxone distribution and lessons learned Philipp Lobmaier, MD, PhD Norwegian Centre.
ROOM project Addressing the Opioid Epidemic in the U.P.
Know the facts: Series II
MDHHS Response to the Opioid Crisis
Opiate Roundtable March 29, 2018 Karen Burgess, MD
Opioids in Butte County
Opioid-related harms and responses
QC Harm Reduction Opioid Overdose Reversal Training
Impact of Policy and Regulatory Responses to the Opioid Epidemic on the Care of People with Serious Illness Hemi Tewarson, Director, Health Division National.
Naloxone in North Carolina
Act Naloxone Availability
QC Harm Reduction Opioid Overdose Reversal Training
Strategic Initiatives to Address Opioid Overdose & Addiction
Medically assisted treatment
Presentation transcript:

Implementation in Ohio’s Regional Psychiatric Hospitals

Project DAWN Deaths Avoided With Naloxone Developed by ODH to address opioid epidemic facing our state First Ohio program in Portsmouth July 2012 Launched March 2013 in Cuyahoga County

What is Project DAWN? Opioid education and naloxone distribution program (OEND program) Educate at-risk opioid users on: –RISK FACTORS for overdose –RECOGNITION of opioid overdose –RESPONDING by calling 911, administering rescue breathing and NASAL NALOXO NE

Naloxone (Narcan ® ) Naloxone is an opioid antagonist that blocks the effects of opioid mu-receptors in the brain to restore breathing in an overdose victim. It is a prescription drug, but is not a controlled substance and has no potential for abuse Only reverses opioids like heroin, morphine, methadone, OxyContin, Percocet and Vicodin It has no effect on other drugs such as benzodiazepines or alcohol

Overdose Kits contain: 2 vials of Naloxone 2 mg/2 ml 2 nasal atomizers Educational DVD Quick reference guide and educational pamphlet ID card Information on drug treatment programs in the community

How is a person rescued? Administration by self or a 3 rd party similar to an Epi-pen would be given to a person having an allergic reaction By law, the drug can only be given to the person who is the intended recipient Family and friends are encouraged to attend, but the drug (by state law) can only go to the user

Three Popular FAQs 1.Does this encourage drug use? 2.Is it safe for lay responders to give? 3.Does this discourage utilization of hospital services?

OEND FAQs Does this encourage drug use? Naloxone puts users into withdrawal which is an unpleasant experience. Several studies have shown that access to naloxone does not encourage people to use more drugs or use in riskier ways

OEND FAQs Participants were trained in overdose prevention and their knowledge of heroin overdose management increased while heroin use decreased Same study also showed that drug treatment entry increased after participation in OEND program Seal, KH., R. Thawllet, et al Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study. J Urban Health 83(2): (2005) Participants were trained in overdose prevention and their knowledge of heroin overdose management increased while heroin use decreased Same study also showed that drug treatment entry increased after participation in OEND program Seal, KH., R. Thawllet, et al Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study. J Urban Health 83(2): (2005)

OEND FAQS OEND FAQS Participants in naloxone programs reported no interest in increasing their dosage or injecting more frequently as a result of naloxone availability Sarz Maxwell et al., Prescribing Naloxone to Actively Injecting Heroin Users: A Program to reduce heroin Overdose Deaths, 25(3) Journal of Addictive Diseases (2006) Participants in naloxone programs reported no interest in increasing their dosage or injecting more frequently as a result of naloxone availability Sarz Maxwell et al., Prescribing Naloxone to Actively Injecting Heroin Users: A Program to reduce heroin Overdose Deaths, 25(3) Journal of Addictive Diseases (2006)

Massachusetts Experience- decrease in opioid overdose mortality in communities with OEND programs Walley A, Xuan Z, Hackman H, et al. Opioid Overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ 2013; 346:f174.

Heroin-related Deaths San Francisco,

IS IT SAFE FOR LAY RESPONDERS TO GIVE? YES. It has been shown that with basic training drug users are able to recognize and respond to an opioid overdose. In fact, Green et al. found that trained drug users were as competent as medical experts in recognizing opioid overdose and indication for naloxone

OEND FAQs Does this discourage utilization of hospital services? NO. A NYC program reported that 74% of participants in their OEND program called 911 which is similar to the rate at which non-participants will utilize EMS Does this discourage utilization of hospital services? NO. A NYC program reported that 74% of participants in their OEND program called 911 which is similar to the rate at which non-participants will utilize EMS

The AMA supports OEND programs The AMA adopted a policy in June of 2012 to support further implementation of community-based programs that offer naloxone and other opioid overdose prevention services.

Ohio State Medical, Pharmacy, and Nursing Board Joint Regulatory Statement Purpose: to endorse the prescription of naloxone to high risk individuals by educating prescribers on the proper use of naloxone to those who are high risk for opioid overdose To promote wider utilization of naloxone by high –risk individuals

Cost/Benefit Estimate  Total Cost of Project DAWN Kit = $50.00  Medical Cost of a Fatal Drug Overdose: $ 2,980  Naloxone can prevent complications that result in costly drug overdose-related hospital stays. In 2008, the average in-patient treatment charge for a drug overdose is $10,488.

Naloxone distribution in practice settings Community distribution sites Outpatient clinics Health Depts Emergency Dept Inpatient units Law enforcement ( in some counties)

What are we doing in RPHs? Prescribing Guidelines Treatment Guidelines OARRS Care plans SAMI NALOXONE Project DAWN Prescribing Guidelines Treatment Guidelines OARRS Care plans SAMI NALOXONE Project DAWN

Project DAWN: Why for RPHs? Increasing admissions with Opiate Use Disorders Multiple risk factors for lethal overdose – Psychiatric disorder – Other medications – Smoking status Overrepresented in mortalities following discharge

Naloxone distribution at Inpatient setting Patients are identified as Opiate dependent SAMI counselor completes intake and training. Social Worker duplicates and reinforces the program. Meets with family and friends. Pharmacy is notified Discharge prescription is completed by physician Nursing and or pharmacy Reviews discharge plan with patient and locations for refills

NBH Program Evaluated the NBH Opiate patient population SAMI counselor participates in the Cuyahoga Opiate task force Initially partnered with Free Clinic and MetroHealth (very important for refills) Developed an internal process Currently 37 kits have been distributed in two months, and one reversal admitted through Metro.

Bringing Project DAWN to scale Based on success of Project DAWN at NBH, implementation is proceeding at all 6 RPH sites around Ohio Target date for full system implementation: March 1, 2014

ODMHODADAS

Contacts Ohio MHAS Central Office Brad DeCamp, MPA SAMI Social Work Kim Patton LISW Director of Social Work SAMI Director at NBH Pharmacy Alan Pires M.S RPh Director of Pharmacy NBH Ohio MHAS Central Office Brad DeCamp, MPA Medical Training Joan Papp MD, FACEP Medical Director, Project DAWN Cuyahoga County (216)

tDAWN.aspxhttp:// tDAWN.aspx tDAWN.aspxhttp:// tDAWN.aspx